Apolipoprotein C3 in diabetic nephropathy in type 1 diabetes and its role in cardiovascular disease

被引：0
|
作者：
Stechemesser, L. [1 ]
Forsblom, C. [2 ,3 ,4 ]
Tolonen, N. [2 ,3 ,4 ]
Taskinen, M. -R. [5 ]
Weitgasser, R. [6 ]
Groop, P. -H. [2 ,3 ,4 ]
机构：
[1] Paracelsus Med Univ LKH, Salzburg, Austria
[2] Folkhalsan Res Ctr, Folkhalsan Inst Genet, Helsinki, Finland
[3] Univ Helsinki, Abdominal Ctr Nephrol, Helsinki, Finland
[4] Helsinki Univ Hosp, Helsinki, Finland
[5] Univ Helsinki, Heart & Lung Ctr, Helsinki, Finland
[6] Diakonissen Wehrle Hosp, Dept Med, Salzburg, Austria
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1012
引用
收藏
页码：S497 / S497
页数：1
相关论文
共 50 条
  • [1] Apolipoprotein C3 and Cardiovascular Disease in Patients with Type 1 Diabetes and Diabetic Nephropathy
    Stechemesser, Lars
    Forsblom, Carol
    Weitgasser, Raimund
    Groop, Per-Henrik
    DIABETES, 2018, 67
  • [2] Apolipoprotein C3 levels are elevated in diabetic nephropathy and cardiovascular disease in type 1 diabetes
    Stechemesser, Lars
    Forsblom, Carol
    Tolonen, Nina
    Taskinen, Marja-Riitta
    Paulweber, Bernhard
    Weitgasser, Raimund
    Groop, Per-Henrik
    WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 : 361 - 361
  • [3] Apolipoprotein C3 and its predictive role in cardiovascular disease in type 1 diabetes
    Stechemesser, Lars
    Forsblom, Carol
    Tolonen, Nina
    Taskinen, Marja-Riitta
    Paulweber, Bernhard
    Weitgasser, Raimund
    Groop, Per-Henrik
    WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 : 361 - 361
  • [4] Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes
    Kanter, Jenny E.
    Shao, Baohai
    Kramer, Farah
    Barnhart, Shelley
    Shimizu-Albergine, Masami
    Vaisar, Tomas
    Graham, Mark J.
    Crooke, Rosanne M.
    Manuel, Clarence R.
    Haeusler, Rebecca A.
    Mar, Daniel
    Bomsztyk, Karol
    Hokanson, John E.
    Kinney, Gregory L.
    Snell-Bergeon, Janet K.
    Heinecke, Jay W.
    Bornfeldt, Karin E.
    JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (10): : 4165 - 4179
  • [5] Multifaceted Role of Apolipoprotein C3 in Cardiovascular Disease Risk and Metabolic Disorder in Diabetes
    Pan, Bo-Yi
    Chen, Chen-Sheng
    Chen, Fang-Yu
    Shen, Ming-Yi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (23)
  • [6] Elevated apolipoprotein C3 augments diabetic kidney disease and associated atherosclerosis in type 2 diabetes
    Cervantes, Jocelyn
    Koska, Juraj
    Kramer, Farah
    Akilesh, Shreeram
    Alpers, Charles E.
    Mullick, Adam E.
    Reaven, Peter
    Kanter, Jenny E.
    JCI INSIGHT, 2024, 9 (12)
  • [7] Apolipoprotein C3 aggravates diabetic nephropathy in type 1 diabetes by activating the renal TLR2/NF-KB pathway
    Wang, Huan
    Huang, Xiaomin
    Xu, Pengfei
    Liu, Xuejing
    Zhou, Zihao
    Wang, Fuhua
    Li, Jingyi
    Wang, Yuhui
    Xian, Xunde
    Liu, George
    Huang, Wei
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 119
  • [8] Silencing Apolipoprotein C3 Prevents Diabetic Kidney Disease And Atherosclerosis In A Mouse Model Of Type 2 Diabetes
    Cervantes, Jocelyn
    Kramer, Farah
    Yoshida, Kazue
    Mun, Grace
    Alpers, Charles E.
    Mullick, Adam E.
    Kanter, Jenny E.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2022, 42
  • [9] Control of serum triglyceride levels by the apolipoprotein C3 gene and its relationship to cardiovascular disease
    Davidson, Jillian
    Rotondo, Dino
    CURRENT OPINION IN LIPIDOLOGY, 2018, 29 (03) : 271 - 272
  • [10] Cardiovascular disease and diabetic control in type 1 diabetes
    Corrall, R. J. M.
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2006, 36 (01): : 40 - 40
12345